{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:57:41Z","timestamp":1794333461542,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472062"],"award-info":[{"award-number":["82472062"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473298"],"award-info":[{"award-number":["82473298"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62102103"],"award-info":[{"award-number":["62102103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202148,82502479"],"award-info":[{"award-number":["82202148,82502479"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2508603"],"award-info":[{"award-number":["2023YFC2508603"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515011672"],"award-info":[{"award-number":["2024A1515011672"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["U22A20345"],"award-info":[{"award-number":["U22A20345"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.eclinm.2025.103551","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T23:27:27Z","timestamp":1759879647000},"page":"103551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["AI-derived longitudinal and multi-dimensional CT classifier for non-small cell lung cancer to optimize neoadjuvant chemoimmunotherapy decision: a multicentre retrospective study"],"prefix":"10.1016","volume":"89","author":[{"given":"Guanchao","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2928-9530","authenticated-orcid":false,"given":"Zhitao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinting","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongde","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3521-2535","authenticated-orcid":false,"given":"Lizza E.L.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1612-9055","authenticated-orcid":false,"given":"Leonard","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"De Ruysscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0422-7996","authenticated-orcid":false,"given":"Andre","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-5935","authenticated-orcid":false,"given":"Zhenwei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2025.103551_bib1","doi-asserted-by":"crossref","DOI":"10.1200\/JCO-24-02239","article-title":"Neoadjuvant nivolumab plus ipilimumab versus chemotherapy in resectable lung cancer","volume":"43","author":"Awad","year":"2025","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103551_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jama.2023.24735","article-title":"Perioperative toripalimab plus chemotherapy for patients with resectable non-small cell lung cancer: the neotorch randomized clinical trial","volume":"331","author":"Lu","year":"2024","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.eclinm.2025.103551_bib3","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJMoa2311926","article-title":"Perioperative nivolumab in resectable lung cancer","volume":"390","author":"Cascone","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103551_bib4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non-small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.eclinm.2025.103551_bib5","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resectable non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103551_bib6","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S1470-2045(24)00498-4","article-title":"Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial","volume":"25","author":"Provencio","year":"2024","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103551_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","article-title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","volume":"19","author":"Havel","year":"2019","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103551_bib8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jtho.2024.10.010","article-title":"Adjuvant immunotherapy should not be used in patients with a pathologic complete response to neoadjuvant chemoimmunotherapy","volume":"20","author":"Phillips","year":"2025","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103551_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.5896","article-title":"Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy","volume":"5","author":"Smith","year":"2019","journal-title":"JAMA Oncol"},{"issue":"10093","key":"10.1016\/j.eclinm.2025.103551_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(17)31056-5","article-title":"Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial","volume":"390","author":"Rullier","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103551_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(25)00027-0","article-title":"Neoadjuvant chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer (SANO trial): a multicentre, stepped-wedge, cluster-randomised, non-inferiority, phase 3 trial","volume":"26","author":"van der Wilk","year":"2025","journal-title":"Lancet Oncol"},{"issue":"10027","key":"10.1016\/j.eclinm.2025.103551_bib12","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","article-title":"Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial","volume":"387","author":"Herbst","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103551_bib13","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jtho.2022.09.109","article-title":"Predictive biomarkers for immunotherapy in lung cancer: perspective from the international association for the study of lung cancer pathology committee","volume":"17","author":"Mino-Kenudson","year":"2022","journal-title":"J Thorac Oncol"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103551_bib14","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jtho.2021.03.028","article-title":"Prevalence and heterogeneity of PD-L1 expression by 22C3 assay in routine population-based and reflexive clinical testing in lung cancer","volume":"16","author":"Hwang","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103551_bib15","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1016\/j.cell.2025.03.018","article-title":"A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer","volume":"188","author":"Liu","year":"2025","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103551_bib16","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S1470-2045(20)30453-8","article-title":"Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial","volume":"21","author":"Provencio","year":"2020","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103551_bib17","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1097\/RLU.0000000000005863","article-title":"Prognostic value of 18F-FDG PET\/CT metabolic parameters in resectable non-small cell lung cancer treated with neoadjuvant immunotherapy plus chemotherapy","volume":"50","author":"Cheng","year":"2025","journal-title":"Clin Nucl Med"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103551_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc.2016.36","article-title":"Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy","volume":"16","author":"Topalian","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.eclinm.2025.103551_bib19","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat Commun"},{"issue":"21","key":"10.1016\/j.eclinm.2025.103551_bib20","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMra2301725","article-title":"The current and future state of AI interpretation of medical images","volume":"388","author":"Rajpurkar","year":"2023","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103551_bib21","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41591-022-01981-2","article-title":"Multimodal biomedical AI","volume":"28","author":"Acosta","year":"2022","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103551_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41568-024-00694-7","article-title":"A guide to artificial intelligence for cancer researchers","volume":"24","author":"Perez-Lopez","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.eclinm.2025.103551_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104364","article-title":"Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a multicentre study","volume":"86","author":"She","year":"2022","journal-title":"eBioMedicine"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103551_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009348","article-title":"Non-invasive multimodal CT deep learning biomarker to predict pathological complete response of non-small cell lung cancer following neoadjuvant immunochemotherapy: a multicenter study","volume":"12","author":"Ye","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.eclinm.2025.103551_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101899","article-title":"Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study","volume":"58","author":"Huang","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.eclinm.2025.103551_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105311","article-title":"Multiregional dynamic contrast-enhanced MRI-based integrated system for predicting pathological complete response of axillary lymph node to neoadjuvant chemotherapy in breast cancer: Multicentre study","volume":"107","author":"Li","year":"2024","journal-title":"eBioMedicine"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103551_bib27","article-title":"Longitudinal MRI-driven multi-modality approach for predicting pathological complete response and B cell infiltration in breast cancer","volume":"12","author":"Huang","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103551_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011773","article-title":"NeoPred: dual-phase CT AI forecasts pathologic response to neoadjuvant chemo-immunotherapy in NSCLC","volume":"13","author":"Zheng","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103551_bib29","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1007\/s00330-023-10241-x","article-title":"Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"34","author":"Han","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eclinm.2025.103551_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101562","article-title":"Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: a multicentre, retrospective cohort study","volume":"52","author":"Liu","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.eclinm.2025.103551_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103551_bib32","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jtho.2024.01.019","article-title":"The international association for the study of lung cancer staging project for lung cancer: proposals for the revision of the M descriptors in the forthcoming ninth edition of the TNM classification for lung cancer","volume":"19","author":"Fong","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103551_bib33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103551_bib34","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41571-023-00794-7","article-title":"Immune-checkpoint inhibition for resectable non-small-cell lung cancer - opportunities and challenges","volume":"20","author":"Mountzios","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103551_bib35","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jtho.2024.06.010","article-title":"Neoadjuvant and adjuvant treatments for early stage resectable NSCLC: consensus recommendations from the international association for the study of lung cancer","volume":"19","author":"Spicer","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103551_bib36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/jamaoncol.2015.3638","article-title":"Quantitative assessment of the heterogeneity of PD-L1 expression in non-small-cell lung cancer","volume":"2","author":"McLaughlin","year":"2016","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103551_bib37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/annonc\/mdz003","article-title":"Novel patterns of response under immunotherapy","volume":"30","author":"Borcoman","year":"2019","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103551_bib38","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s00330-024-11141-4","article-title":"CT radiomics to predict pathologic complete response after neoadjuvant immunotherapy plus chemoradiotherapy in locally advanced esophageal squamous cell carcinoma","volume":"35","author":"Shi","year":"2025","journal-title":"Eur Radiol"},{"issue":"7","key":"10.1016\/j.eclinm.2025.103551_bib39","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1016\/S2589-7500(23)00082-1","article-title":"Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study","volume":"5","author":"Saad","year":"2023","journal-title":"Lancet Digit Health"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103551_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009616","article-title":"Intratumoral and peritumoral radiomics of MRIs predicts pathologic complete response to neoadjuvant chemoimmunotherapy in patients with head and neck squamous cell carcinoma","volume":"12","author":"Lin","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.eclinm.2025.103551_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.937277","article-title":"CT-based radiomics in predicting pathological response in non-small cell lung cancer patients receiving neoadjuvant immunotherapy","volume":"12","author":"Lin","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.eclinm.2025.103551_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1327779","article-title":"Non-invasive prediction for pathologic complete response to neoadjuvant chemoimmunotherapy in lung cancer using CT-based deep learning: a multicenter study","volume":"15","author":"Qu","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.eclinm.2025.103551_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1414954","article-title":"CT-based quantification of intratumoral heterogeneity for predicting pathologic complete response to neoadjuvant immunochemotherapy in non-small cell lung cancer","volume":"15","author":"Ye","year":"2024","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103551_bib44","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1078-0432.CCR-24-1926","article-title":"Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns of acquired resistance to immunotherapy in patients with NSCLC","volume":"31","author":"Mazzaschi","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103551_bib45","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41467-021-22188-y","article-title":"Predicting treatment response from longitudinal images using multi-task deep learning","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103551_bib46","article-title":"MRI-based quantification of intratumoral heterogeneity for predicting treatment response to neoadjuvant chemotherapy in breast cancer","volume":"308","author":"Shi","year":"2023","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103551_bib47","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1038\/s41467-024-47512-0","article-title":"Enhancing NSCLC recurrence prediction with PET\/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights","volume":"15","author":"Sujit","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.eclinm.2025.103551_bib48","doi-asserted-by":"crossref","DOI":"10.1097\/JS9.0000000000002821","article-title":"Multichannel deep learning prediction of major pathological response after neoadjuvant immunochemotherapy in lung cancer: a multicenter diagnostic study","author":"Geng","year":"2025","journal-title":"Int J Surg"},{"key":"10.1016\/j.eclinm.2025.103551_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2025.112171","article-title":"Non-invasive CT based multiregional radiomics for predicting pathologic complete response to preoperative neoadjuvant chemoimmunotherapy in non-small cell lung cancer","volume":"189","author":"Fan","year":"2025","journal-title":"Eur J Radiol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025004845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025004845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:05:09Z","timestamp":1778904309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025004845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":49,"alternative-id":["S2589537025004845"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103551","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AI-derived longitudinal and multi-dimensional CT classifier for non-small cell lung cancer to optimize neoadjuvant chemoimmunotherapy decision: a multicentre retrospective study","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103551"}}